baber/WOPTO huggingface dataset:
Patent MX-2020003831-A (MX)
Inventor: HILL JAMES RONALD
IPC: G01R31/08
Filed: 2018-10-17
Abstract: Un sistema para ensayos no destructivos de un componente eléctrico energizado aéreo; el sistema tiene una base, una fuente de rayos X, un generador de imágenes digital de rayos X y un controlador del generador de imágenes; el sistema tiene, además, un blindaje flexible eléctricamente conductor, desmontable, el cual se adapta para acoplarse operativamente a, y para encapsular, por lo menos la base, la fuente de rayos X, el generador de imágenes digital de rayos X y el controlador del generador de imágenes, con el fin de formar un sistema enfundado; en una posición de uso, cuando el sistema enfundado se posiciona adyacente al componente eléctrico energizado, con el fin de ensayar no destructivamente el componente eléctrico energizado, el blindaje protege por lo menos la base, la fuente de rayos X, el generador de imágenes digital de rayos X y el controlador del generador de imágenes de campos eléctricos alrededor del componente eléctrico energizado, permitiendo al mismo tiempo una comunicación de señales entre por lo menos la fuente de rayos X y el componente eléctrico energizado.
Patent MX-2020006254-A (MX)
Title: Oral care compositions.
Inventor: BRUNELLA ANDRE
IPC: A61K8/02
Filed: 2017-12-18
Abstract: Oral care compositions and methods for reducing dental sensitivity or at least partially occluding dentin tubules of teeth in a subject are described herein. The oral care compositions may include an orally acceptable vehicle and a silica blocking agent configured to at least partially occlude dentin tubules of teeth. The silica blocking agents may include silica particles having a particle size distribution (D95) less than or equal to 7 Î¼m and a BET surface area of greater than or equal to 150 m<sup>2</sup>/g.
Patent MX-2020006343-A (MX)
Title: Improved diluent for cell-associated alphaherpesvirus vaccine.
Inventor: DE GROOF AD
IPC: A61K39/12
Filed: 2018-12-19
Abstract: The present invention relates to the use of a diluent for the in-use stabilisation of cells infected with a cell- associated alphaherpesvirus. Contrary to the long-standing practice of incorporating a considerable amount of peptone into the diluent for such virus-infected cells, it was found that a reduction of the amount of protein in the diluent improved the in-use stability of alphaherpesvirus-infected cells. Whereby the best stability was even obtained using a protein-free diluent. This effect was especially pronounced for recombinant HVT viruses expressing a heterologous insert. Being protein-free is highly advantageous for the production of the diluent, in respect of costs, safety, and consistency of production.
Patent MX-2020006472-A (MX)
Title: Glucosamine derivatives for the prevention or treatment of joint disorders.
Inventor: WANG LIN
IPC: A61P19/02
Filed: 2018-12-17
Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis and osteoporosis.
Patent MX-2020007042-A (MX)
Title: SYSTEMS AND METHODS FOR REDUCING THE FORMATION OF IMPURITIES DURING 244bb DEHYDROCHLORINATION TO 1234yf.
Inventor: CHIU YUON
IPC: C07C21/18
Filed: 2019-01-08
Abstract: The present disclosure provides various manufacturing processes for the production of 2,3,3,3-tetrafluoropropene (HFO-1234yf or 1234yf). Such methods may allow for the improved yields, more economical processes, and waste reduction in the production of 1234yf and subsequent processes.
Patent MX-2020007964-A (MX)
Title: Product and contractor service mapping for computer-mediated reality systems.
Inventor: BANHIDY TODD
IPC: G06Q30/06
Filed: 2019-01-29
Abstract: A computer-mediated reality system electronically communicates computer-mediated presentation information for a product to a purchaser device. The computer-mediated reality system electronically receives a selection of the product. The computer-mediated reality system automatically places a product code for the product in an electronic shopping cart. The computer-mediated reality system electronically communicates computer-mediated offer information for a contractor service to the purchaser device. The computer-mediated reality system electronically receives a selection of the contractor service. The computer-mediated reality system automatically places a service code for the contractor service in the electronic shopping cart, the service code electronically received from a mapping computer system, the service code automatically derived by the mapping computing system programmed to map the product with the contractor service. The computer-mediated reality system electronically communicates electronic shopping cart information to the purchaser device with a request to complete a purchase of the product and the contractor service.
Patent MX-2020008311-A (MX)
Title: Biopolymer derived from the conversion of human hair.
Inventor: VARGAS HERNANDEZ Zayra
IPC: C05F17/05
Filed: 2020-08-07
Abstract: The present invention relates to a novel perception of human hair, which comes from hairdressers, aesthetics, barbershops, and beauty salons. The processes consist of the collection, cutting, sifting or screening, washing, cleaning, and disinfection, obtaining a natural biopolymer useful as a raw material in the production of products required by the agricultural, industrial, and environmental sectors. The conversion of human hair creates new opportunities in the agricultural sector by improving soil properties and helping agricultural productivity. The sum of impacts and benefits support actions in the area of ??Food Sovereignty. In the industrial and construction sectors, alternatives are being opened to elaborate advanced materials, taking advantage of their biomechanical properties. In environmental activities, solutions are addressed in the absorption of industrial substances, hydrocarbons and oils, soil remediation, and production of biofuels for supporting actions therein.
Patent MX-2020009193-A (MX)
Title: Sunscreen with a reduced tendency to stain textiles, containing hydrogenated vegetable oil and bis-ethylhexyloxyphenol methoxyphenyl triazine.
Inventor: LERG HEIKE
IPC: A61K8/92
Filed: 2019-02-08
Abstract: The invention relates to a cosmetic preparation containing hydrogenated vegetable oil, in particular hydrogenated rapeseed oil, and 2,4-bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyp henyl)-1,3,5-triazine (INCI bis-ethylhexyloxyphenol methoxyphenyl triazine), and processes and uses of hydrogenated vegetable oil, in particular hydrogenated rapeseed oil, in the protection of textiles from lasting discolorations caused by cosmetic preparations that contain UV filters (in particular bis-ethylhexyloxyphenol methoxyphenyl triazine).
Patent MX-2020009470-A (MX)
Title: Pharmaceutical or food supplement preparation based on alpha-lactalbumin.
Inventor: MAINARDI PAOLO
IPC: A61P25/24
Filed: 2019-03-13
Abstract: Pharmaceutical or food supplement preparation including alpha-lactalbumin and at least one short-chain fatty acid (SCFA) or a precursor or derivative thereof for use in the treatment of disorders of the central nervous system; the SCFA or its precursor or derivative may be contained in at least one first dosage unit together with a carrier acceptable from the pharmaceutical or food standpoint and the alpha-lactalbumin in at least one second dosage unit together with a carrier acceptable from the pharmaceutical or food standpoint, and said dosage units may be distinct units intended for simultaneous or separate administration or the preparation may consist of a pharmaceutical or food supplement composition comprising the at least one short-chain fatty acid or a precursor or derivative thereof and alpha-lactalbumin together with a carrier acceptable from the pharmaceutical or food standpoint.
Patent MX-2020010129-A (MX)
Title: Treatment of a cancer by microbiome modulation.
Inventor: HENN MATTHEW
IPC: A61K35/747
Filed: 2019-03-28
Abstract: Methods are provided for identifying donors of fecal matter that can improve a subject's response to a checkpoint inhibitor in the treatment of cancer. Methods and compositions are also provided for using donated fecal matter in the treatment of cancer.
Patent MX-2020010507-A (MX)
Title: Additive manufacturing apparatus, system, and method.
Inventor: KNECHT FREDERICK
IPC: B23K26/34
Filed: 2019-04-05
Abstract: An apparatus for producing a three-dimensional object using a resin or other flowable material in a layer-by-layer technique uses a roller or other applicator to carry a layer of the flowable material to an application site, an exposure device to emit electromagnetic waves to apply the layer to the object to build the object, and optionally further including an initial exposure with emitted electromagnetic waves to at least partially solidify the layer of the flowable material prior to the roller carrying the layer to the application site.
Patent MX-2020010729-A (MX)
Title: Stable anti-cd79b immunoconjugate formulations.
Inventor: LIU JUN
IPC: C07K16/28
Filed: 2019-04-12
Abstract: The disclosure provides stable pharmaceutical compositions comprising an anti-CD79b immunoconjugate and a surfactant. The disclosure also provides methods for using such compositions for the treatment of cancer.
Patent MX-2020011329-A (MX)
Title: Maize event dp-023211-2 and methods for detection thereof.
Inventor: HU XU
IPC: C12N15/82
Filed: 2019-04-22
Abstract: Embodiments disclosed herein relate to the field of plant molecular biology, specifically to DNA constructs for conferring insect resistance to a plant. Embodiments disclosed herein relate to insect resistant corn plant containing event DP-023211-2, and to assays for detecting the presence of event DP-023211-2 in samples and compositions thereof.
Patent MX-2020012882-A (MX)
Title: Extract and dermatological composition comprising same, for treating sensitive skin.
Inventor: CASTEX-RIZZI NATHALIE
IPC: A61P17/04
Filed: 2019-05-31
Abstract: The invention relates to a new bacterial extract that can be used for protecting and/or treating sensitive skin and/or reactive, intolerant skin, particularly by means of targeted action on neurogenic inflammation of the skin. The invention also relates to cosmetic or dermatological compositions comprising such a bacterial extract as an active ingredient.
Patent MX-2020013185-A (MX)
Title: Processes for commencing operations of fluidized catalytic reactor systems.
Inventor: PRETZ MATTHEW T
IPC: B01J8/00
Filed: 2019-06-26
Abstract: A process for commencing a continuous reaction in a reactor system includes introducing a catalyst to a catalyst processing portion of the reactor system, the catalyst initially having a first temperature of 500 C or less, and contacting the catalyst at the first temperature with a commencement fuel gas stream, which includes at least 80 mol% commencement fuel gas, in the catalyst processing portion. Contacting of the catalyst with the commencement fuel gas stream causes combustion of the commencement fuel gas. The process includes maintaining the contacting of the catalyst with the commencement fuel gas stream until the temperature of the catalyst increases from the first temperature to a second temperature at which combustion of a regenerator fuel source maintains an operating temperature range in the catalyst processing portion.
Patent MX-2020014315-A (MX)
Title: Heteroaryl compounds for treating huntington's disease.
Inventor: WOLL MATTHEW G
IPC: A61P25/14
Filed: 2019-06-25
Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted benzothiazole compounds of Formula (I) or (II), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
Patent MX-2021000219-A (MX)
Title: Audio apparatus and method of operation therefor.
Inventor: KOPPENS JEROEN GERARDUS HENRICUS
IPC: H04R1/10
Filed: 2019-07-09
Abstract: An audio apparatus, e.g. for rendering audio for a virtual/ augmented reality application, comprises a receiver (201) for receiving audio data for an audio scene including a first audio component representing a real-world audio source present in an audio environment of a user. A determinator (203) determines a first property of a real-world audio component from the real-world audio source and a target processor (205) determines a target property for a combined audio component being a combination of the real-world audio component received by the user and rendered audio of the first audio component received by the user. An adjuster (207) determines a render property by modifying a property of the first audio component indicated by the audio data for the first audio component in response to the target property and the first property. A renderer (209) renders the first audio component in response to the render property.
Patent MX-2021002856-A (MX)
Title: Methods of treating immunotherapy-related toxicity using a gm-csf antagonist.
Inventor: DURRANT CAMERON
IPC: C07K16/28
Filed: 2019-09-10
Abstract: Methods for neutralizing and/or removing human GM-CSF in a subject in need thereof, comprising administering to the subject CAR-T cells having a GM-CSF gene knockout (GM-CSF<sup>k/o</sup> CAR-T cells) are provided. Also provided are methods for <i>GM-CSF</i> gene inactivation or <i>GM-CSF</i> knockout (KO) in a cell comprising targeted genome editing or GM-CSF gene silencing. Methods for preventing/treating immunotherapy-related toxicity, comprising administering to the subject CAR-T cells having a <i>GM-CSF</i> gene inactivation or <i>GM-CSF</i> knockout (GM-CSF<sup>k/o</sup> CAR-T cells), wherein the <i>GM-CSF</i> gene is inactivated or knocked out and/or a recombinant GM-CSF antagonist are provided. Methods for reducing a level of a cytokine or chemokine other than GM-CSF in a subject having immunotherapy-related toxicity comprising administering to the subject a recombinant hGM-CSF antagonist are provided. Also provided are methods for treating or preventing immunotherapy-related toxicity in a subject, comprising administering to the subject chimeric antigen receptor-expressing T-cells (CAR-T cells), the CAR-T cells having a GM-CSF gene knockout (GM-CSF<sup>k/o</sup> CAR-T cells). Methods for preventing or reducing blood-brain barrier disruption in a subject treated with immunotherapy, the method comprising administering CAR-T cells having a GM-CSF gene knockout (GM-CSF<sup>k/o</sup> CAR-T cells) to the subject, also are provided.
Patent MX-2021003644-A (MX)
Title: Porous metal foil or wire and capacitor anodes made therefrom and methods of making same.
Inventor: HORIO ISAYUKI
IPC: H01G9/048
Filed: 2019-10-30
Abstract: A porous metal foil and porous metal wire are described. Capacitor anodes made from either or both of the porous metal foil and porous metal wire are further described as well as methods to make same.
Patent MX-2021004109-A (MX)
Title: Communication between a controller and a controlled device over a wireless network.
Inventor: PEPE TERESA
IPC: G05B19/418
Filed: 2018-10-11
Abstract: A method of communication between a controlled device and a controller over a 3GPP wireless network performed at a source interface device. The method comprises: splitting (102) an incoming traffic into a first path carrying a native ethernet traffic and a second path carrying an IP, internet protocol, traffic; remapping (106) IP addresses of packets of the IP traffic with an IP address of a destination interface device at a remote end of the 3GPP wireless network; encapsulating (104) the native ethernet traffic into IP traffic with the IP address of the destination interface device at a remote end of the 3GPP wireless network and scheduling (108) IP traffic from said first path and said second path for transmission (110) to the destination interface device via the 3GPP wireless network.
Patent MX-2021006284-A (MX)
Title: Refrigerated display case with shelf indexing system.
Inventor: STUBBLEFIELD STEVE
IPC: A47F3/00
Filed: 2021-05-27
Abstract: A refrigerated display case is provided. The refrigerated display case includes a rear wall has a first end, a second end disposed opposite the first end and a plurality of markings disposed between the first end and the second end. A mounting rail is coupled to the rear wall. A shelf is adjustably coupleable to the mounting rail at a plurality of positions between the first end and the second end of the rear wall. The plurality of markings are configured to indicate a distance from the first end of the rear wall to the shelf based on alignment of the shelf with at least one of the plurality of markings.
Patent MX-2021006853-A (MX)
Title: Flow modulation device for dispensing pressurized fluids.
Inventor: YOUNG LINCOLN C
IPC: B05B7/24
Filed: 2019-12-17
Abstract: A flow modulation device 300 for controlling a rheological state of a dispensed pressurized fluid includes a porous element 304 and an exit tube. The porous element 304 is in fluid communication with a distal end of an outlet tube 303 and receives pressurized fluid in a first rheological state. The porous element 304 includes a plurality of channels that divide a flow channel into a plurality of flow paths through which the pressurized fluid flows and that modulates the flow of the pressurized fluid. The exit tube 305 includes proximal end 355 and distal end 345 and an intermediate body including a sidewall 365 defining a hollow internal lumen 375. The exit tube 305 is in fluid communication with the porous element 304 and receives the modulated pressurized fluid from the plurality of flow paths and refocuses the fluid to dispense the pressurized fluid in a second rheological state.
Patent MX-2021007462-A (MX)
Title: Method and brake controller for controlling a brake of an elevator system.
Inventor: LINDEGGER URS
IPC: B66B1/32
Filed: 2019-12-18
Abstract: The invention relates to a method for controlling a brake (3) of an elevator system (1), and to a brake controller (25) controlling said method. The brake (3) in this case comprises an armature (15), which is drawn by an electromagnet (17) against a spring force into a release position in order to release the brake (3) from a brake position. The method comprises the following steps: applying an initial electric voltage to the electromagnet (17) and measuring an amperage I(t) then fed to the electromagnet (17); and reducing the voltage applied to the electromagnet (17) to a holding voltage in response to an identification of a typical behaviour over time of the measured amperage I(t) which occurs characteristically when the armature (15) is moved from the braking position into the release position. The method enables the brake (3) to be activated more quickly in certain situations from a released state into a braking state.
Patent MX-2021009346-A (MX)
Title: Universal retractable padlock.
Inventor: ISPIZUA ACASUSO JOSU
IPC: E05B77/44
Filed: 2021-08-03
Abstract: The present invention relates to a padlock for covers of railway containers or similar, such as hoppers, doors, and gates, which prevents them from being opened. Also, it includes a mount to hide all the joints, screws, and locks of the covers adjusted by a fixed blocking system on one side and mobile on the other.
Patent MX-2021009506-A (MX)
Title: Treatment involving car-engineered t cells and cytokines.
Inventor: SAHIN UGUR
IPC: A61K39/00
Filed: 2020-02-06
Abstract: The present disclosure relates to methods and agents for enhancing the effect of T cells engineered to express chimeric antigen receptors (CARs). These methods and agents are, in particular, useful for the treatment of diseases characterized by diseased cells expressing an antigen the CAR is directed to. Specifically, the present disclosure relates to methods comprising providing to a subject T cells genetically modified to express a chimeric antigen receptor (CAR) and administering to the subject IL2 or a polynucleotide encoding IL2. The methods of the disclosure may comprise administering IL2 or a polynucleotide encoding IL2 and a further cytokine or a polynucleotide encoding a further cytokine, wherein the further cytokine may be IL7 or IL21. The T cells genetically modified to express a CAR may be provided to the subject by administering the T cells genetically modified to express a CAR or by generating the T cells genetically modified to express a CAR in the subject. The methods of the disclosure may further comprise administering to the subject an antigen or a variant thereof, or a polynucleotide encoding an antigen or a variant thereof, wherein the T cells genetically modified to express a CAR are targeted to the antigen. In one particularly preferred embodiment, the polynucleotides administered according to the present disclosure are RNA.
Patent MX-2021009672-A (MX)
Title: Rna-guideded transcriptional regulation.
Inventor: MALI PRASHANT G
IPC: C12N15/11
Filed: 2015-12-04
Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including introducing into the cell a first foreign nucleic acid encoding one or more RNAs complementary to DNA, wherein the DNA includes the target nucleic acid, introducing into the cell a second foreign nucleic acid encoding a nuclease-null Cas9 protein that binds to the DNA and is guided by the one or more RNAs, introducing into the cell a third foreign nucleic acid encoding a transcriptional regulator protein or domain, wherein the one or more RNAs, the nuclease-null Cas9 protein, and the transcriptional regulator protein or domain are expressed, wherein the one or more RNAs, the nuclease-null Cas9 protein and the transcriptional regulator protein or domain co-localize to the DNA and wherein the transcriptional regulator protein or domain regulates expression of the target nucleic acid.
Patent MX-2022002795-A (MX)
Title: Protective clothing.
Inventor: HAYASHI YUICHIRO
IPC: A41D13/00
Filed: 2020-09-01
Abstract: Protective clothing with a pair of sleeve portions and a garment body, the protective clothing having a first fabric and a second fabric and being provided with one or multiple joint-covering portions for covering the wearer's elbow joints and/or knee joints, wherein the first fabric has a moisture permeability of at least 200 g/m2/hr, a viral barrier property of at least level 4, a blood barrier property of at least level 4, and a bending stiffness of 60-110 mm, the second fabric is disposed in the joint-covering portions and has a viral barrier property of at least level 4, a blood barrier property of at least level 4, and a bending stiffness of 20-50 mm; and the surface area of the first fabric with respect to the surface area of the protective clothing overall is 15-70%.
Patent MX-2022004335-A (MX)
Title: Bi-aryl dihydroorotate dehydrogenase inhibitors.
Inventor: KUDUK SCOTT
IPC: A61K31/497
Filed: 2020-10-09
Abstract: Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula I as follows: Formula I wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, and Q are defined herein.